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Research efforts have focused mainly on the hormonal aspects of canine pyometra for more 
than 6 decades. However, this disease is often manifested as systemic illness in response to 
the bacterial uterine infection.  
Studies I-II were undertaken to clarify bacteriological aspects of canine pyometra; i.e. the 
origin of the infecting bacteria, the infecting bacteria’s impact on severity of the systemic 
illness and the presence of bacterial endotoxin in the systemic circulation. Study I, a 
bacterio-epidemiologic study, investigated the predominant bacteria, Escherichia coli, using 
biochemical fingerprinting. The homogeneity among E. coli populations, isolated from 
various sites in bitches with pyometra and from faeces of healthy dogs, was determined.  
Study II, a clinical study of bitches with pyometra, determined uterine bacterial species, 
haematology, blood biochemical parameters and plasma endotoxin levels. The impact of 
infecting bacteria on blood parameters and clinical status was studied. Study III investigated 
if bitches with pyometra display the Systemic Inflammatory Response syndrome (SIRS) and 
if SIRS relates to outcome. Systemic levels of interleukin-6 (IL-6), C - reactive protein 
(CRP) and tumor necrosis factor α (TNFα) were determined, investigating a possible 
correlation between these inflammatory markers and SIRS or outcome. Study IV used 
clinical parameters, haematology, blood biochemical parameters, CRP and TNFα to 
clinically differentiate pyometra from the often preceding uterine condition cystic 
endometrial hyperplasia (CEH). 
Study I revealed that E. coli isolated from bitches with pyometra show high level of 
homogeneity indicating that E. coli associated with pyometra may have properties, yet 
undetermined, in common. Identical clones of E. coli were found in the faeces and uterus of 
bitches with pyometra, indicating an ascending infection route. Study II failed to show 
systemic endotoxemia in bitches with pyometra, but showed many other signs of systemic 
affection in blood parameters. Study III showed that 57 % of pyometra cases fulfil clinical 
criteria for SIRS and that SIRS criteria are correlated to increased length of hospitalization. 
Body temperature, heart rate and CRP correlated to SIRS and CRP correlated to outcome. 
Study IV revealed that clinical signs and levels of percent band neutrophils and CRP aid in 
the differentiation of CEH from pyometra.  
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ΩΩΩ 
 
Tucked away in our subconscious is an idyllic vision. We see ourselves on a long 
trip that spans the continent. We are traveling by train. Out the windows we drink 
in the passing scene of cars on nearby highways, of children waving at a crossing, 
of cattle grazing on a distant hillside, of smoke pouring from a power plant, of row 
upon row of corn and wheat, of flatlands, and valleys, of mountains and rolling 
hillsides, of city skylines and village halls. 
 
But uppermost in our minds is the final destination. Bands will be playing and 
flags waving. Once we get there our dreams will come true, the pieces of our lives 
will fit together like a jigsaw puzzle. How restlessly we pace the aisles, damning 
the minutes for loitering—waiting, waiting, waiting for the station. 
 
“When we reach the station, that will be it!” we cry. 
“When I’m 18.” 
“When I buy a new Mercedes Benz.” 
“When I get a promotion, I shall live happily ever after!” 
 
Sooner or later, we must realize there is no station, no one place to arrive once 
and for all. The true joy of life is the trip. The station is only a dream. It constantly 
outdistances us. 
 
So stop pacing the aisles and counting the miles. Instead, climb more mountains, 
eat more ice cream, go barefoot more often, swim more rivers, watch more 
sunsets, laugh more, cry less. Life must be lived as we go along. The station will 
come soon enough. You should enjoy the ride, not wait for the station. 
 
ΩΩΩ 
 
After Robert J. Hastings “The Station” 
With permission, Southern Illinois University Press, Carbondale, USA. 
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Introduction 
 
The Pathogenesis of Canine Pyometra, a Background 
History and definition 
Mankind has struggled with existential questions like “where did we come from, 
and what are we doing here?” since before the time when Aristotle (884-322 B.C.) 
approached these questions in a scientific manner. Similar questions could be 
applied to the pathogenesis of canine pyometra, a topic that has triggered the 
interest of veterinarians since the 1930’s (Teunissen, 1938). However, more than 
six decades of studies have still not led to a complete understanding of the 
pathogenesis of pyometra.  
 
Canine pyometra is a disease affecting the adult intact bitch, causing a variety of 
clinical signs of genital and systemic disease. The concept of cystic endometrial 
hyperplasia (CEH) - Pyometra, was introduced by Dow (1957) and stated that 
hormonal changes lead to CEH, which predisposes the uterus to secondary 
infection, leading to pyometra. Before Dow’s investigations the condition had been 
described under a variety of names. Dow (1957, 1958, 1959a, 1959b) described 
the development of pyometra from a pathological-anatomical point of view. He 
concluded that the pus-distended uterus seen in pyometra is the end result of a 
series of uterine changes. These changes range from the uncomplicated CEH, over 
inflammatory changes in the endometrium in combination with CEH, to the end 
stage; chronic purulent endometritis, with pus accumulation in the uterus. The 
gradual transition makes it challenging to define pyometra morphologically and 
clinically. However, definitions of pyometra as an acute or chronic polysystemic 
disease in mature bitches (Hardy & Osborne, 1974) or an acute or chronic 
endometritis (Boerresen, 1975) occurring in metestrus, appears generally accepted. 
Lately, the classical CEH-pyometra complex has been challenged. It has been 
suggested that in some cases the development of pyometra is a separate entity from 
CEH, with a hormonal component in the pathogenesis but mainly triggered by 
bacterial infection (De Bosschere et al., 2001). 
 
Hormonal component 
Traditional theories suggest that hormonal changes render the uterus susceptible 
for infection. This understanding was originally based on work by Teunissen 
(1952) and Dow (1957, 1958, 1959a, 1959b), who investigated the importance of 
estrogen and progesterone in the development of endometritis. They found that the 
cystic and inflammatory changes of the uterus associated with endometritis could 
be reproduced by injections of progesterone. Estrogen alone seemed to play a less 
important role, but appeared to enhance the endometrial response to progesterone, 
and exogenous estrogen administration, used to terminate pregnancy, has been 
reported to increase the risk for pyometra (Bowen et al., 1985). Progesterone 
stimulates endometrial glandular secretion and suppresses contractions of the 
uterus, and thus creates an intrauterine environment predisposing to bacterial 
growth (Cox, 1970). Several authors investigated whether prolonged or excessive   10
progesterone production would be responsible for the development of pyometra, 
but failed to show such disturbances (Christie, 1972; Hadley, 1975; Chauffaux & 
Thibier, 1978; Austad et al., 1979). More recently, the possibility of an 
exaggerated endometrial response to progesterone and/or estrogen has been 
investigated (Dhaliwal et al., 1999; De Bosschere et al. 2002). Presently, there is 
no conclusive evidence for changes in these hormon receptors being responsible 
for the development of pyometra. Interestingly enough, De Bosschere and co-
workers (2001) found that the expression of estrogen and progesterone receptors 
differed significantly between uteri of bitches with CEH and uteri of bitches with 
pyometra, and suggested that these differences indicate different pathogenesis of 
the two conditions. The expression of androgen receptors in the uterus was found 
to be significantly decreased in bitches with pyometra as compared to healthy 
bitches (Sauerwein et al., 1998). 
 
Bacteriological component 
In the past, investigations of the bacteria associated with canine pyometra have 
been few. However, multiple authors have reported a predominance of Escherichia 
coli (Asheim, 1965; Renton et al., 1971; Grindlay et al., 1973; Sandholm et al., 
1975; Kivisto et al., 1977; Vandesplassche, 1991; Dhaliwal et al., 1998). 
Sandholm and co-workers (1975) found that E. coli adheres to receptors in the 
progesterone-stimulated endometrium, which might be one explanation for the 
observed predominance of this bacterium. Grindlay and co-workers (1973) found 
that certain serotypes of E. coli, e.g. 02, 04, 06, and 075, were more commonly 
associated with pyometra than others. Dhaliwal and co-workers (1998) concluded 
that E. coli serotype 032 and 04 were the most commonly prevalent in their study 
population. In addition, they found that Cytotoxin Necrotizing Factor (CNF) was 
expressed in 7/16 (44%) serotypes associated with pyometra. Certain serotypes 
appeared to affect the endometrium more severely than others, and the presence of 
CNF was associated with more severe endometrial changes.  
 
The route of infection of the uterus was early on suggested to be hematogenic or 
lymphogenic as well as ascending (Dow, 1959b). The ascending route was not 
supported by the work of Meyers-Wallen and co-workers (1986), who observed 
that the type of bacteria isolated from the vagina did not necessarily represent the 
bacterial species isolated from the uterus in pyometra. Sandholm and coworkers 
(1975) showed that cystitis was commonly associated with canine pyometra, and 
that the E. coli bacteria isolated from the urinary bladder and the isolate from the 
uterus showed many similarities. It was suggested that the urinary tract may serve 
as a bacterial reservoir, and bacteria ascend into the uterus during a susceptible 
stage in the estrous cycle (Sandholm et al., 1975). 
 
Clinical signs and laboratory parameters in pyometra 
Common clinical signs of pyometra are not limited to the genital tract, e.g. vaginal 
discharge, but include systemic signs such as vomiting and/or inappetence, 
polyuria /polydipsia and lethargy. (Dow, 1957; Borresen, 1979; Nelson & 
Feldman, 1986; Stone et al., 1988). It has been suggested that the clinical signs are  11 
more severe in cases where the cervical canal is occluded (Dow, 1958, Borresen, 
1975). However, the cervix may spontaneously open or close during the disease, 
causing intermittent vaginal discharge or a sudden deterioration in the clinical 
status of the bitch (Studdert, 1971). 
    
The systemic effects of pyometra are reflected by several laboratory parameters. 
The most characteristic alteration is an inflammatory leukogram with marked 
elevation of the total white blood cell count (WBC) and usually a regenerative left 
shift in the differentiated WBC count (Dow, 1957; Sandholm et al., 1975; De 
Shepper et al., 1986; Stone et al., 1988; Wheaton et al., 1989; Sevelius, 1990). 
Other common blood work abnormalities include a normocytic, normochromic 
anemia. The anemia has been suggested to be caused by decreased erythropoesis, 
so called anemia of chronic disease, and by loss of erythrocytes into the uterine 
lumen (Shalm, 1973). Anemia of chronic disease can be caused by a variety of 
disorders including chronic inflammation, in which lactoferrin and other acute-
phase reactants mediate an iron sequestration within the myeloid cells in the bone 
marrow, withdrawing iron from the normal erythropoiesis (Nelson & Couto, 1998). 
Hyperglobulinemia with a pronounced hypoalbuminemia, bilirubinemia, 
hypercholesterolemia and increases in alkaline phosphatase (AP), aspartate 
aminotransferase (ASAT) and lactate dehydrogenase (LD) have also been 
associated with pyometra. In contrast, serum alanine aminotransferase (ALAT) is 
usually significantly decreased (Borresen, 1980; De Schepper et al., 1987; Capiau 
et al., 1987). Asheim (1964) suggested that the cause of hyperglobulinemia, 
concurrent with hypoalbuminemia was due to renal loss of albumin, but later 
studies have demonstrated only a mild to moderate urinary protein loss (Borresen 
& Skrede, 1980; Sevelius et al., 1990), and interpreted the changes in serum 
proteins as part of an acute phase reaction (Borresen & Skrede, 1980). The 
elevated levels of ALP, bilirubin and serum cholesterol have been considered to be 
due to intrahepatic cholestasis (Borresen, 1980). The enzymes ASAT and LD, 
which are normally present in the liver as well as in skeletal and heart muscle, are 
often elevated in pyometra cases (Borresen & Skrede, 1980). Borresen & Skrede 
(1980) suggested that the elevated levels of ASAT and LD more likely are derived 
from muscle breakdown than hepatocellular insult. This suggestion was based on 
the observation of increases in the muscular enzyme creatine kinase (CK) and 
decreased activity of ALAT (Borresen & Skrede, 1980; De Schepper et al., 
1987a), indicating that no hepatocellular damage has occurred. Subsequent 
examinations of liver biopsy specimens showed fatty infiltration and bile pigments, 
consistent with cholestasis, but no gross hepatocellular necrosis (Borresen, 1980; 
Sevelius  et al., 1990). De Schepper and co-workers (1987a) suggested that 
endotoxin-related liver dysfunction may be responsible for the observed increase in 
the ASAT and the decrease in ALAT concentration. 
 
Azotemia in canine pyometra is seen in 15-31 % of cases (increased serum 
creatinine and/or elevated blood urea nitrogen, BUN)(Borresen, 1980; De 
Schepper et al., 1987a; De Schepper et al., 1987b). Asheim (1963-1965) studied 
the renal dysfunction. He concluded that disturbances in the release of antidiuretic 
hormone from the hypothalamus-pituitary gland were unlikely reasons for the 
polyuria in bitches with pyometra (Asheim 1963).  Supporting this conclusion, 
further studies revealed pathological changes in the kidney, which shared   12
morphological features with glomerulinephritis in humans and were reversible after 
ovariohysterectomy (Asheim, 1965; Obel et al., 1964). Asheim suggested that the 
presence of bacteria in the uterus was responsible for the decreased urine 
concentration ability. Furthermore, he reported that injection of E. coli toxin 
induced a reversible reduction in the renal concentrating ability. Later authors have 
suggested that this effect was caused by endotoxin (Borresen, 1975). This theory 
was contradicted by Stone and co-workers (1988) who found neither structural 
glomeruli changes nor the presence of bacteria in the uterus to correlate with the 
loss of urinary concentration ability. However, De Schepper and co-workers 
(1989) found indications of glomerular damage in 54 of 74 (73%) bitches with 
pyometra, as reflected by proteinuria, either alone or in combination with tubular 
lesions, the latter indicated by elevated urinary levels of gamma-glutamyl 
transferase (GGT). More recent investigations of renal dysfunction in canine 
pyometra showed that 13/55 dogs (24%) showed increase of GGT and/or N-acetyl-
beta-glucosaminidase, which are enzyme markers for tubular damage. The increase 
in urinary enzymes was sometimes associated with decreased glomerular filtration 
rate (Heinene, Moe & Molmen, 2001). 
 
Endotoxin in pyometra 
Blood endotoxin concentrations have been shown to relate to severity of clinical 
signs and mortality in canine pyometra. Endotoxin concentrations in dogs that died 
from pyometra were significantly higher than in bitches with a good outcome 
(74.2±18.3 pg/ml versus 9.5 ±18.3 pg/ml) (Okano et al., 1998). Borresen & Naess 
(1977) did not find endotoxemia whereas another study demonstrated endotoxemia 
with mean plasma endotoxin concentrations of 438 pg/ml in 15 bitches with 
pyometra prior to surgery (Wessels & Wells, 1989).  
 
The lipopolysachharide endotoxin (ET) is a cell wall component of E. coli and 
other gram-negative bacteria, and is released either from bacterial cell death and 
disruption, or during vigorous growth of the bacteria (Crutchley et al., 1967). 
Normally, small amounts of ET from the intestinal bacterial flora are absorbed into 
the portal blood and transported to the liver, where it is eliminated in two steps 
(Nolan, 1988; Fox et al., 1990). The Kuppfer cells trap the ET and modify it, to 
facilitate uptake by the hepatocytes. The hepatocytes then partially detoxify and 
eliminate the modified ET. Clearance of ET from the portal blood is very rapid and 
occurs within minutes (Fox et al., 1990). The partially degraded ET is slowly 
excreted from the body, mainly through the gut. Another route of ET excretion, 
under normal circumstances less important, is through the lungs, where 
macrophages carrying ET migrate to the lung and pass into the alveolar and 
bronchiolar space (Freudenberg & Galanos, 1988). 
 
Systemic effects of ET are seen only when the ET clearance capacity of the liver 
is exceeded (spill-over effect) (Okano et al., 1993). When ET has gained entrance 
into the circulation, a broad spectrum of biological effects may occur. Among the 
beneficial effects are generalized stimulation of the immune system and microbial 
killing. On the other hand, a massive release of ET often causes irreversible shock 
and death (Rietschel & Brade, 1992). Experimentally, sub-lethal doses of ET have  13 
been shown to cause fever, lethargy and an increase in heart and respiration rate 
(Van Miert & Frens, 1968). Higher ET doses in dogs lead to hemorrhagic diarrhea 
and vomiting (Hardie & Kruse-Elliot, 1990). Initial hemodynamic changes lead to 
portal hypertension, hepatosplanchnic pooling of blood, and a decrease in central 
venous blood pressure, cardiac output and systemic blood pressure (Hardie & 
Kruse-Elliot, 1990). In endotoxic shock, these early changes are transitory and 
normal values are regained, but with inadequate treatment the condition progresses 
to refractory hypotension. Myocardial failure and death are usually the outcome of 
severe endotoxic shock. Histopathologically, changes including congestion of liver 
and kidneys, hepatocellular necrosis, mild pulmonary edema as well as 
subendocardial, adrenal and gastrointestinal tract hemorrhage have been noted 
(Hardie & Kruse-Elliot, 1990). The molecule ET is not directly cytotoxic but 
interacts with inflammatory cells, mainly macrophages, platelets and vascular 
endothelium resulting in the release of a cascade of inflammatory mediators, such 
as cytokines (Tumor Necrosis Factor, Interleukin-1, -6, -8), lipid mediators 
(thromboxane, prostaglandins, platelet-activating factor) and oxygen free radicals 
(Rietchel & Brade, 1992). In response to these primary mediators, multiple 
secondary mediators are released and together the mediators induce inflammatory 
changes and cell death (Hardie & Kruse-Elliot, 1990). 
 
Severity of clinical signs has also been related with degree of 
immunosuppression in dogs with pyometra (Faldyna et al., 2001). 
Immunosuppression was reflected by a decrease in circulating actively 
phagocytosing neutrophils and monocytes in the peripheral blood, and by 
inhibition in lymphocyte activity. The lymphocyte inhibition activity could be 
transferred with serum of bitches with low lymphocyte activity to cell cultures of 
normal lymphocytes. Serum from bitches with pyometra showed higher 
immunoglobulin content, and circulating immune-complexes and lysozyme. The 
clinically most affected dogs also showed the most pronounced changes in these 
tests, and clinical status was directly proportional to the level of leukocytosis and 
lymphopenia in these dogs (Faldyna et al., 2001). The suppression of lymphocyte 
activity may be induced by endotoxemia. Bacterial products or components could 
be one reason for impaired immune response and human endotoxemia has been 
associated with decreased production of pro-inflammatory cytokines (Granowitz et 
al., 1993). 
 
Systemic inflammatory response syndrome  
Systemic inflammatory response syndrome (SIRS) is the clinical manifestation of a 
response to an inciting stimulus, severe enough to cause systemic release of 
circulating inflammatory mediators (Purvis & Kirby, 1994; Brady & Otto, 2001).  
Any severe injury or infection can potentially lead to SIRS, such as pancreatitis, 
heat stroke, burns, multiple trauma or pan-systemic neoplasia (Purvis & Kirby, 
1994). Sepsis is a classical disease manifested as SIRS and sepsis is indeed defined 
as SIRS resulting from infection (Purvis & Kirby, 1994; Hardie, 1995). Canine 
pyometra is another common disease suggested to result in SIRS and is like sepsis 
associated with bacterial infection (Hardie, 1995). However, the frequency with 
which dogs with pyometra are displaying SIRS has not been determined. Early   14
identification of patients affected by SIRS is critical due to the risk for fatal 
complications resulting from progression of this syndrome. The critically ill patient 
with SIRS is at risk for development of Multiple Organ Dysfunction Syndrome 
(MODS), which carries a high mortality rate despite recent years advances in 
critical care (Brady & Otto, 2001; Deitch & Goodman, 1999). Even the less 
severely affected patient with SIRS is at risk for MODS if a reactivation of the 
inflammatory response occurs, often caused by a perceivable minor event such as a 
catheter site infection, the so called “two hit” theory (Sasdua & Schein, 1999). An 
imbalanced immune response to pro-inflammatory cytokines such as interleukin-1 
(IL-1), IL-6 and tumor necrosis factor alpha (TNFα) has been considered the 
reason for progression of SIRS into multiple organ dysfunction (Brady & Otto, 
2001; Deitch & Goodman, 1999). In humans, clinical criteria have been 
established in order to recognize SIRS (Bone et al., 1992) and these criteria have 
shown a significant correlation with mortality and/or morbidity as reflected by 
physiologic deterioration and increasing organ dysfunction (Muckart & 
Bhagwanjee, 1997; Pietrantoni et al., 2003; Bochicchio et al., 2002; Buter et al., 
2002; Afessa et al., 2001; Sun & Aikawa, 1999; Bossink et al., 1998; Shoenberg, 
Weiss & Radermacher, 1998).  The limits for clinical criteria used in people, 
including fever or hypothermia, tachycardia, hypocapnea or tachypnea, increased 
or decreased white blood cell count and/or increased band neutrophils, have been 
adapted for use in dogs. The clinical criteria as presented by Purvis & Kirby 
(1994), Hardie (1995) and Hauptman, Walshaw & Olivier (1997) are presented in 
Table 1. 
 
Table 1. Clinical criteria of systemic inflammatory response syndrome (SIRS) and their 
limits for use in dogs in three studies. SIRS is suspected if two of four criteria are present in 
a canine patient 
 
Criteria  Purvis & Kirby 
(1994) 
Hardie (1995)  Hauptman, 
Walshaw & 
Olivier (1997) 
Temperature (°C)  <37.8; >39.7  <38.0; >40.0  <38.1; >39.2 
Heart rate (beats/ 
min) 
>160 >120  >120 
Respiratory rate 
(breaths/min) 
>20 >20  >20 
WBC (x 10
3/µL); 
band neutrophils 
<4, >12; >10 %  <5, >18; >5 %  <6, >16; >3 % 
 
Hauptman, Walshaw & Olivier (1997) investigated the sensitivity and specificity 
of the different limits for detection of sepsis. They found that the previously 
suggested limits showed sensitivity in the detection of sepsis of only 77-83% 
(Hauptman, Walshaw & Olivier, 1997). With further modifications of the limits for 
these criteria, Hauptman reached a sensitivity of 97%, minimizing the risk for the 
serious consequences that can result from failure to identify sepsis, i.e. SIRS, 
before the onset of organ dysfunction. However, with the limits defined to increase 
sensitivity, the numbers of false positive results in the identification of sepsis 
increased (specificity 64%) (Hauptman, Walshaw & Olivier, 1997).  
  15 
Multiple human studies have evaluated different inflammatory mediator’s ability 
to more specifically act as markers for sepsis/SIRS and predictors of outcome 
(Reny  et al. 2002; Marik, 2002; Harbarth et al., 2001; Whicher et al. 2001; 
Bossink et al., 1998). In human critical care, plasma TNFα has been shown to 
increase with SIRS and MODS (Spielmann et al., 2001) and increases in IL-6 and 
the acute phase protein C-reactive protein (CRP) were detected in infected patients 
with SIRS (Gogos et al., 2001).  
 
Human CRP was first detected in 1930 and was named for its ability to bind the 
C polysaccharide of Streptococcus pneumoniae (Tillet & Francis, 1930). C-
reactive protein is mainly synthesized by the liver as part of the acute phase 
response after hepatocyte stimulation with pro-inflammatory cytokines such as IL-
6, IL-1 and transforming growth factor β (Young , Gleeson & Cripps, 1999).  The 
function of CRP is not fully understood but this protein does show anti-
inflammatory properties (Zouki et al., 1997; Tilgh et al.,1993). Alone or together 
with procalcitonin, CRP has been shown to be a valuable marker for sepsis in 
critically ill people (Reny et al., 2002; Suprin et al., 2000). In addition, CRP has 
shown to be of great diagnostic importance in atherosclerotic cardiovascular 
disease where it has predictive value (Kereiakes, 2003). In dogs, several studies 
have shown a significant increase of CRP over the base-line value in 
experimentally induced inflammation (Hayashi et al., 2001; Otabe et al. 2000; 
Yamashita et al. 1994). However, only a couple of clinical studies of CRP in dogs 
are available. A group of veterinarians in Poland reported increased levels of CRP 
in bitches with pyometra (Krzyzanowski et al., 2000) and another report showed 
CRP elevations in dogs with various disorders and surgical traumas (Yamamoto et 
al., 1993). 
 
    16
Aims of the study 
 
The purpose of this investigation was to: 
 
•  Determine the most prevalent bacterial species in canine pyometra and the 
origin of this bacterium. 
 
•  Determine if the bacterial species of the uterine infection is related to severity 
of disease or to the presence of endotoxemia. 
 
•  Identify the frequency of the systemic inflammatory response syndrome in 
canine pyometra. 
 
•  Identify biochemical markers for severity of the systemic inflammatory 
response in pyometra. 
 
•  Identify biochemical markers able to predict outcome in canine pyometra. 
 
•  Identify biochemical or clinical markers for differentiation between pyometra 
and cystic endometrial hyperplasia. 
 
   17 
Material and methods  
 
Animals, data and sample collection (I-IV) 
All bitches with pyometra included in studies I through IV were client-owned 
clinical cases seen at the Dept. of Small Animal Clinical Sciences, Swedish 
University of Agricultural Sciences, Uppsala, Sweden. The studies were approved 
by the Swedish Animal Ethical Committee prior to onset of the investigations. All 
dogs obtained the presumptive diagnosis of pyometra after history review, physical 
examination and/or diagnostic imaging and they underwent subsequent 
ovariohysterectomy. Final diagnosis was verified through histopathologic 
examination of uteri. 
 
In study I-II the bitches included were clinical cases seen at the Dept. of Small 
Animal Clinical Sciences, from 1991 to 1994. As control animals served clinically 
healthy laboratory beagles. Blood samples for hematology, biochemical panels and 
plasma endotoxin determinations were obtained immediately pre-operatively in all 
dogs. In dogs with the presumptive diagnosis pyometra, an additional set of blood 
samples were obtained approximately 48 hours after surgery. These samples were 
transported without delay to the clinical laboratory, Department of Clinical 
Chemistry, Uppsala, Sweden. Blood samples for hematology and biochemical 
panels were handled according to the routines for the laboratory, and plasma from 
endotoxin-free heparinized vials were separated by centrifugation and frozen in –
20 ˚C for later endotoxin determination. 
 
Study III-IV included bitches seen at the Dept. of Small Animal Clinical 
Sciences from 2001 to 2002. Control animals included one group of clinically 
healthy age-matched intact female dogs boarding at the clinic. In addition, controls 
included one group of dogs that previously had been enrolled in the study 
(pyometra cases) and where the owner of the dog agreed to return the healthy 
animal to the clinic for repeat physical examination and blood work, a minimum of 
8 weeks after surgery. In all dogs, blood samples were obtained pre-operatively or, 
in control animals, after hospital admission of the dog. The samples were 
immediately placed on ice and then transported without delay to the clinical 
pathology laboratory.  Blood samples for hematology and biochemical panels were 
handled according to the routines for the laboratory, and plasma from EDTA vials 
were separated and frozen in –70 ˚C for subsequent IL-6, TNFα and CRP 
determinations. 
 
Bacteriological examination (I-II) 
A 1x2 cm biopsy of the uterine wall was aseptically collected immediately 
following ovariohysterectomy and placed in thioglycollate medium USP (one liter 
of medium contained 5 g yeast extract, 15 g tryptone, 5.5 g dextrose, 0.5 g Na-
thioglycollate, 2.5 g NaCl, 0.5 g L-cystine, 0.001 g resazurin and 0.5 g agar no.1). 
The specimens were subjected to bacteriological examination within 12 hours of 
collection and were cultured by aerobic incubation on 5% (v/v) horse blood and 
bromocresol-purple agar plates (one liter containing 10 g balanced pepton [LabM   18
MC4), 10 g Lab M agar No. 2 [MC6], 10 g lactose and 1 ml 1.6% bromocresol-
purple in ethanol). For bacteriological examination standard procedures were used 
(Carter & Cole, 1990). For anaerobic examination the uterine biopsies were 
cultured on Fastidious Anaerobe Agar plates (Lab M, Axel Johnson Lab System 
Inc., Solna, Sweden). 
 
Rectal swab samples from healthy dogs were cultured on Mac Conkey agar 
plates (Difco, Detroit, MI, USA). After 18 hours incubation at 37 ˚C, one E. coli 
colony, representing the macroscopically morphologically dominant colony type, 
from each dog was subcultured on 5% (v/v) horse blood agar plates. Rectal swabs 
from dogs with pyometra were cultured on Mac Conkey agar plates (Difco, 
Detroit, MI, USA). To ensure representation of at least one colony of the dominant 
E. coli in the samples, after 18 hours incubation at 37 ˚C, six colonies from each 
sample were subcultured on 5% (v/v) horse blood agar plates. 
 
Identification of E. coli was based on positive response to B-nitrophenyl-B-D-
glucopyranosiduronic acid (PGUA) and indol production. Isolates negative for one 
or both of these tests were identified using the API 20E system (API System S.A., 
La Balme les Grottes, France). Escherichia coli isolates from dogs with UTI were 
kindly provided by Dr. A. Franklin (National Veterinary Institute, Uppsala, 
Sweden). Further strains of E. coli from UTI were isolated at the Section of 
Clinical Microbiology, Swedish University of Agricultural Sciences, Uppsala, 
Sweden, according to routine methods. 
 
Biochemical fingerprinting of bacteria (I) 
Biochemical fingerprinting was performed using the PhenePlate® (PhP) System 
(BioSys Inova, Stockholm, Sweden) which is based on quantitative and kinetic 
measurements of biochemical reactions of the bacteria. The system consists of 
twenty-four biochemical reagents, selected based on high discriminating ability 
between non-related E. coli (Kühn, 1985; Kühn  et al., 1990), and the system 
software for numerical data analysis. The method has been described in great detail 
previously (Kühn, 1985). Briefly, 10 µl of bacteria from a 24 h (37 ˚C) E. coli 
culture on 5% (v/v) horse blood agar plate was suspended in 10 ml substrate 
containing 0.1% peptone and 0.1% bromthymol blue in distilled water. The 
suspension was thereafter vigorously shaken before 150 µl was dispensed into each 
of 24 wells, representing 24 biochemical reagents, of the microtiter plate.The 
absorbance (620 nm) for each reaction was read after 7, 24 and 48 hours 
incubation at 37 ˚C in an optical microplate reader. After the final reading the 
mean absorbance value from each test was calculated yielding ‘biochemical 
fingerprints’, for each isolate and defined by a numerical value ranging from 0 
(acidic reaction) to 25 (alkaline reaction) (Kühn, 1985). 
 
The relationship between each isolate was determined by pair-wise comparisons 
and calculated as a correlation coefficient (r). An r > 0.975 indicated that the 
isolates were of the same clone, and considered to be of the same biochemical 
phenotype (PhP-type) (Kühn 1990). A somewhat lower correlation coefficient (r > 
0.960) indicated isolates of high similarity. Isolates with r < 0.950 were regarded 
as not related.   19 
 
The phenotypic diversity of an E. coli population was measured using Simpson’s 
index of diversity (Di) (Kühn et al., 1990). Di is high in populations consisting of 
many different phenotypes and low if certain PhP-types dominate in the population 
(range 0.0-1.0). 
 
The biochemical homogeneity of a population was calculated as the mean of the 
correlation coefficients (rmean), indicating whether the population is derived from a 
normal, random population of bacteria or contains groups of related bacteria. 
 
Plasma endotoxin determination (II) 
Samples for endotoxin determination was collected in endotoxin-free heparinized 
vacutainer tubes (Endotubes, Chromogenix, Goteborg, Sweden).  Plasma was 
separated by centrifugation and thereafter collected in plastic vials (A/S Nunc, 
Roskilde, Denmark) in which they were stored at –70 ˚C prior to transport. They 
were transported, cooled, over less than 24 hours to the analyzing laboratory Scan 
Dia Laboratory Services I/S, Charlottenlund, Denmark. This commercial 
laboratory utilizes a kinetic turbidometric Limulus amebocyte lysate (LAL) assay 
for endotoxin determinations. This assay is approved for endotoxin determinations 
by the Food and Drug Administration, USA (1987). 
 
Pathologic examination (II-IV) 
Following ovariohysterectomy the whole uterus including ovaries was fixed in 10 
% neutral buffered formalin. The uterus’ gross appearance was documented and 
the presence of yellow bodies, corpora lutea, in the ovaries noted. Representative 
sections from each uterine horn were embedded in paraffin and stained with 
Hematoxylin &Eosine. 
 
The histopathological diagnosis of pyometra was based on fulfilment of the 
criteria for chronic purulent metritis, purulent endometritis or purulent metritis, as 
proposed by Boerresen (1975). Chronic purulent metritis was characterized by a 
macroscopically distended uterus with irregular endometrial surface. 
Microscopically, varying numbers of neutrophils, plasmacells and lymphocytes 
were observed in the mucosa. These cell types were also present to a lesser extent 
in the myometrium. The endometrial epithelium was hyperplastic and cystic with 
columnar cells indicating progesterone influence. Cysts often contained large 
amounts of neutrophils. In some cases a varying degree of fibrosis and/or erosions 
in the mucosa was seen. In purulent endometritis, observed inflammatory cells 
were mostly neutrophils and cellular infiltration was limited to the endometrium, 
whereas in purulent metritis inflammatory changes were also present in deeper 
layers of the uterine wall. A diagnosis of CEH was based on observation of 
hyperplasia of the endometrium, in combination with cysts of different sizes, 
without inflammatory changes. A diagnosis of mucometra was based on gross or 
microscopical evidence of mucus or serous fluid in the uterine lumen in 
combination with a hyperplastic/cystic or atrophic endometrium.  
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C-reactive protein assay (III-IV) 
C-reactive protein was determined with a commercially available canine ELISA 
(Tridelta Phase™ range canine CRP kit, TriDelta Diagnostics Inc., Plains, NJ, 
USA), which is a solid phase sandwich immunoassay. Plasma samples and CRP 
standard, serially diluted to range from 7.8 to 250 ng/ml, were applied to a 
microplate, with the wells coated with a monoclonal anti-canine CRP antibody, and 
incubated for 15 minutes at 37 ˚C before the plate was decanted and washed with 
diluted buffer.  Anti-canine CRP conjugate was added to the wells and the plate 
incubated for 15 minutes at 37 ˚C before the plate again was decanted and washed 
with diluted buffer.  Finally, TMB substrate was added and the plate incubated for 
15 minutes at room temperature, stop solution added and the absorbance of the 
wells read in a microtiter plate reader at 450 nm using 630 nm as a reference. A 
standard curve was generated using Microsoft® Excel software (1997) and the 
concentration of the samples obtained by inserting mean optical density into the 
function created by the standard curve.  
 
Tumor necrosis factor α assay (III-IV)   
The TNFα concentration in plasma was determined with an ELISA, with reagents 
kindly provided by Dr. W.A. Buurman (University of Maastricht, Maastricht, the 
Netherlands). ELISA tests utilizing this antibody experimentally in dog plasma 
have showed a detection limit of 15 pg/ml, which is 1/60 of the levels achieved 
after sub-lethal doses of endotoxin (Moeniralam et al., 1998). This ELISA test has 
shown a good correlation with the Walter and Eliza Hall Institute of Medical 
Research (WEHI) bioassay and is specific for biologically active TNFα 
(Engelberts et al., 1991).  High-affinity microtiter plates (MaxiSorp F96, Nunc, 
Denmark) were coated with the provided monoclonal antibody for human TNFα 
and incubated for 15 hours at 4 ˚C. The plate was washed by adding diluted PBS 
buffert (one liter containing 2 g of KCl, 2 g of KH2PO4, 80 g NaCl and  29 g 
Na2HPO412H20 in distilled water) with 0.1% BSA (Bovine Albumin, Sigma 
Aldrich Inc., Saint Louis, MO, USA) and incubated for 1 hr at room temperature 
before decanting. Samples and standard titration curve of provided rhTNFα (range 
5 pg/ml – 10 ng/ml) were applied in duplicate, rabbit anti-TNFα, diluted in PBS 
0.1% BSA, was added, and finally goat anti-rabbit peroxidase applied (Cat. No. 
111-035-045, Jackson Immuno Research Laboratories, Inc., West Grove, PA, 
USA). Between and after the three latter steps the plates were incubated at room 
temperature for one hour. TMB peroxidase substrate was added, the reaction 
stopped with 1 M H2SO4 after 15 min, and the plates read in a microtiter plate 
reader at 450 nm. A standard curve was generated using Microsoft® Excel 
software (1997) and the concentration of the samples obtained by inserting mean 
optical density into the function created by the standard curve.  
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Interleukin 6 determination (III) 
The bioactivity of IL-6 in plasma samples was analyzed with a bioassay utilizing 
an IL-6 dependent B-9 hybridoma cell, kindly provided by Dr. Boon Chew, Dept. 
of Animal Science, Washington State University, Pullman, USA. This assay has 
previously shown to be specific for IL-6 (Helle et al., 1988) and has been used 
experimentally in dogs with success (Chew et al., 2000). The IL-6 assay was 
performed as previously described (Fernandez, Botran & Vaclav, 1995). Briefly, 
the B9 hybridoma cell was harvested and washed with washing buffer and with 
culture medium. The cells were centrifuged (200 x g for 10 minutes) and 
resuspended to a density of 20000 cells/ml in culture medium. The diluted test 
samples and rIL-6 standard were incubated for 72 hours with the indicator cell and 
for the final 4 hours with MTT. The samples were analyzed in triplicate including a 
negative control, containing medium only. The cells were harvested and the 
formazan dye formation resulting from the MTT reaction was determined by 
spectrophotometry. Absorbance of the MTT reaction was read at 560 nm (test 
wavelength) and 690 nm (reference wavelength). The detection limit of this assay 
is 0.1 pg/ml. 
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Results and discussion 
 
Bacterio-epidemiologic study (I) 
Escherichia coli were isolated from the uteri of 79 dogs with pyometra (79 
isolates), from the feces of 10 dogs with pyometra (60 isolates) and from the urine 
of 16 bitches (16 isolates) that were suffering from both pyometra and concurrent 
urinary tract infection (UTI). In addition, two separate E. coli populations were 
collected; 91 fecal isolates from 91 healthy, unrelated dogs, and 88 isolates from 
the urinary tracts of unrelated dogs with UTI were kindly provided Dr. A. Franklin, 
the National Veterinary Institute, Uppsala, Sweden.  
 
Biochemical fingerprinting was used for bacterial epidemiological studies of the 
E. coli isolates. This method has proved to be a highly discriminative method, well 
suitable for epidemiological investigations of E. coli (Kühn et al., 1990, Mollby et 
al., 1993). It is rapid, cost effective and suitable for investigations of high numbers 
of samples. The diversity and homogeneity of uterine, urine and fecal E. coli 
populations are presented in table 2. 
 
Table 2. The diversity and homogeneity of 3 different E. coli bacterial populations;   
isolated from  uterus of bitches with pyometra, from urinary tract infection (UTI) and from 
faeces of healthy dogs 
 
Samples Number   
of isolates 
Diversity index  
Di 
Homogeneity 
 rmean 
Pyometra 79  0.98  0.79 
UTI 88  0.97 0.70 
Fecal 91  0.96  0.69 
All samples  258  0.99  0.72 
 
The results revealed that the level of homogeneity of the pyometra E. coli 
isolates was higher (0.79) than the homogeneity among epidemiologically 
unrelated fecal E. coli isolates (0.69). We suggest that this finding could be the 
result of certain serotypes being more prevalent in our pyometra material, in 
accordance with previous studies (Grindlay et al., 1973, Dhaliwal et al., 1998). 
 
Bacteriological examinations were also performed on fecal samples from 10 
bitches with pyometra and showed that at least one of the 6 fecal isolates was 
identical or very similar to the uterine E. coli isolate. Thus, an ascending route of 
infection from the fecal flora into the uterus seems a logical explanation in most 
cases [Wadas (Fransson) et al., 1996]. An ascending infection route is accepted for 
other urogenital disease, such as both canine and human urinary tract infection 
(UTI), where the infecting bacteria most commonly are descendents from the 
intestinal flora (Low et al., 1988, Stamey et al., 1971, Ling et al., 1979). Sandholm 
et al. suggested (1975) that the urinary tract may serve as a bacterial reservoir, and 
infect the uterus during a susceptible stage in the estrus cycle.  Prospective studies 
would be necessary to prove such a theory. It appears more likely that the urinary 
tract might get secondarily infected by the purulent vaginal discharge from a 
pyometra, considering the anatomically dependent position of the urethra opening 
in the female dog.  23 
Of the studied 16 pyometra bitches that also had UTI, the urinary isolate was 
identical or very similar in 14/16 cases (88%). In the remaining two cases (12%) 
the isolates were different. This indicates that the same clone of E. coli found in the 
uterus of bitches with pyometra also caused UTI in most of the bitches. These 
results have subsequently been repeated using another method of bacterial 
subtyping,  i.e. restriction enzyme digestion and pulsed-field gel electrophoresis, 
reported by other members of our research group (Hagman & Kühn, 2002).  
 
Bacteriological findings (II) 
Sixty bitches, representing 34 different breeds with the age ranging from 2- 13 
years were included in this study. Of the 60, 48 bitches received the 
histopathologic diagnosis pyometra, whereas 8 were diagnosed with CEH, 
mucometra, hydrometra or endometrial hyperplasia (Table 3) and 4 dogs showed 
uteri with normal morphology. Eleven clinically healthy laboratory beagles were 
included as controls. 
 
The results of bacteriologic examination of the uteri of 48 bitches with pyometra 
and of 8 bitches with non-inflammatory uterine disease are presented in table 4. 
The study showed that E. coli is by far the most common bacterial isolate in canine 
pyometra, which is in accordance with results from previous studies (Sandholm et 
al., 1975, Kivisto et al., 1977, Dhaliwal et al. 1998). The study also showed that 
bacterial growth in the uterus is present in 98% of cases with histopathologically 
verified diagnosis of pyometra. The 8 cases of non-inflammatory uterine disease 
and the 4 normal uteri showed bacterial growth in only 1/12 cases (8%). The only 
non-pyometra case that did show bacterial growth, a morphologically normal 
uterus, had a mixed culture of low numbers, suggesting that contamination of the 
sample, rather than uterine bacterial infection was present in this case. Therefore, it 
seems reasonable to assume that if pyometra is histopatologically verified, there is 
bacterial infection present in the uterus. The results confirm that non-inflammatory 
uterine disorders such as CEH and mucometra, rarely are associated with infection.   
 
Table 3. Diagnosis in 8 bitches with non-inflammatory uterine conditions. The diagnosis is 
based on the histopathologic findings and/or the gross findings of mucus or fluid in the 
uterus. CEH=Cystic endometrial hyperplasia 
 
Bitch number  Diagnosis 
1  CEH and adenomyosis 
2  Mucometra and endometrial atrophy 
3 Mucometra 
4 Endometrial  hyperplasia 
5 Hydrometra 
6 CEH   
7  CEH and adenomyosis 
8  CEH and adenomyosis 
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Table 4. Results of bacteriologic examination of uteri from 48 bitches with pyometra and 
from 8 bitches with non-inflammatory uterine condition 
 
Bacterial Isolates  Pyometra 
N (%) 
Non-inflammatory 
uterine conditions  
N (%) 
Escherichia coli 43  (90%)  0 
Pasteurella multocida  1 (2%)  0 
Streptococcus canis  1 (2%)  0 
Mixed culture  2 (4%)  0 
No bacterial growth  1 (2%)  8 (100%) 
Total 48  8 
 
Systemic effects of pyometra (II-III) 
Hematology and blood biochemical parameters (II-III) 
Study II investigated total and differential WBC count, including percent band 
neutrophils (PBN) and serum biochemical parameters including; BUN, creatinine, 
glucose, bilirubin, preprandial bile acids, ALAT, ALP and glutamate 
dehydrogenase (GLDH). Three categories female dogs were included, i.e. 
pyometra cases (n=48), bitches with non-inflammatory uterine disorders (n=8), and 
control bitches (n=11). In order to compare the influence of the infecting uterine 
bacteria, the pyometra dogs were divided into pyometra with gram-negative (group 
A) vs. grampositive (group B) uterine infection. Before surgery the control dogs 
were all within normal limits for all the blood values whereas the pyometra dogs in 
group A showed an inflammatory leukogram with a left shift, a decreased BUN, 
increased ALP but decreased ALAT and GLDH. Blood samples were available in 
only 3 dogs in group B, making conclusions of results from group B difficult to 
draw. However, group B showed a significantly (p=0.05) less severe left shift 
(PBN 4.0±2.0) and lower creatinine (75.0±0) compared to the dogs in group A.  
After surgery (applicable only to dogs with pyometra, group A, and dogs with non-
inflammatory uterine disorders), the only differences between groups A and 
controls noted were in the WBC, the PBN and in the ALP. Mean values and 
standard deviations for hematology, blood chemistry parameters and average 
grades of general attitude before surgery are presented in table 5. Table 6 presents 
postoperative hematology and blood biochemical parameters, significantly 
different between pyometra group A, and cases with non-inflammatory uterine 
disorders. Parameters not included in table 5 were not significantly different 
between any of the groups. 
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Table 5. Mean and standard deviation of hematology and blood biochemistry parameters, 
and mean value of general attitude before surgery. Pyometra dogs include dogs with 
histologically confirmed pyometra and gramnegative uterine infection. Dogs with other 
uterine disorders include bitches with non-inflammatory uterine disease and controls 
include healthy dogs with normal uteri * = p-value<0.05, ** = p-value<0.01 and *** =  
p-value<0.001 (two-tailed Student’s T-test, unequal variance) when compared to pyometra 
group. Lack of * indicate no signifificant difference. 
a)  The general attitude was assigned numerical levels with 0=Bright, alert, 1=Quiet, 
alert, 1.5=mildly depressed, 2=moderately depressed (none of the dogs reached 
3=severely depressed  
 
Parameter     Pyometra 
 
Mean(±SD)  count   
Dogs with other 
uterine disorders 
Mean(±SD)  count 
Controls 
 
Mean(±SD)  count 
ALAT 
(µkat/L) 
0.4 (±0.2)         27  0.7 (±0.4)           6  0.7 (±0.1)***   11 
ALP 
(µkat/L)  
2.3 (±1.7)         24  0.6 (±0.4)***     6  1.0 (±0.5)**     11 
Band neutrophils 
 (%) 
9.6 (±12.5)       43  0.5 (±1.4)***     8  0.2  (±0.4)***   11 
Bile acids 
(µmol/L) 
6.4 (±8.9)         25  5.0 (±10.8)         6  16.4 (±15.5)       7 
Bilirubin  
(µmol/L) 
2.8 (±5.7)         25  2.1 (±1.4)           6  2.2 (±2.2)           7 
BUN  
(mmol/L) 
3.4 (±1.3)         27  3.6 (±0.7)           8  10.2 (±3.3)**     7 
Creatinine 
(µmol/L) 
82.2(±17.4)      27  79.7 (±12.9)       6  85.7 (±20.2)     11 
GLDH  
(µkat/L) 
32.6 (±20.0)     26     74.5(±103.0)      6  56.0 (±19.0)**   9
Glucose  
(mmol/L) 
4.8 (±0.9)         17  5.5 (±0.5)           5  Not available 
Lymphocytes  
(%) 
12.1 (±9.7)       43  18.5 (±9.5)         8  22.3 (±7.0)***  11
WBC  
(x 10
9/L) 
27.0 (±17.0)     44  9.4 (±2.9)***     8  11.5 (±4.0)***  11
General  
attitude 
a) 
0.67(±0.6)        41 0.2 (±0.4)*         6  Not applicable 
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Table 6. Mean and standard deviation of selected hematology and blood biochemistry 
parameters, and mean value of general attitude, 2 days after surgery. Pyometra dogs 
include dogs with histologically confirmed pyometra and gramnegative uterine infection. 
Dogs with other uterine disorders include dog with the presumptive diagnose of pyometra, 
but where histopathology revealed  non-inflammatory uterine disorders. *** indicate p-
value <0.001 (calculated by two-tailed Student’s T-test, unequal variance). No * indicates 
no significant difference. 
a) The general attitude was assigned numerical levels with 0=Bright, alert, 1=Quiet, alert, 
1.5=mildly depressed, 2=moderately depressed (none of the dogs reached 3=severely 
depressed) 
  
  Pyometra 
Mean (±SD)        
N  Dogs with other 
uterine disorders 
Mean (±SD)             
N 
ALP  
(µkat/L)
2.7 (±1.2)  16 1.2 (±0.4)*** 4
Band neutrophils 
(%) 
3.9 (±4.5)   26  0.2 (±0.4)***   6 
WBC  
(x 10
9/L) 
45.3 (±23.9)  26 15.2 (±6.0)***   6
General attitude 
a) 
 
0.3 (±0.5)   39  0.2 (±0.4)   6
 
Study III, which included 53 pyometra cases and 19 control dogs, expanded on 
the hematology and blood biochemistry investigations as compared to study II. The 
following hematology parameters were determined: Hct, hemoglobin, RBC, WBC, 
differential count of white blood cells including total count and percentage band 
neutrophils (PBN), nucleated red blood cells, erythrocyte morphology, erythrocyte 
mean volume, erythrocyte hemoglobin content and platelet count. The following 
serum biochemical parameters were determined: ALAT, albumin, ALP, BUN, 
cholesterol, glucose, total protein, sodium, potassium, chloride and calcium. Of 
these parameters, the average values of WBC, PBN, platelet count, albumin and 
ALP, in study III, are presented in Table 6. The average of parameters not included 
in Table 6 differed between pyometra cases and control dogs in PCV, hemoglobin 
and RBC (p-value <0.0001), in serum urea nitrogen (p-value 0.02) and in s-
cholesterol (p-value 0.0004). The average of other parameters did not differ from 
healthy control dogs.  
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Table 7. Mean and standard deviations for clinical parameters (body temperature, heart 
rate, respiratory rate), hematology (WBC, percent band neutrophils, platelet count), blood 
biochemistry (AP, albumin), and inflammatory markers (CRP, TNFα and IL-6) in dogs with 
pyometra and in healthy control dogs. P-values calculated with   Two-sample  unequal 
variance Student’s T-test (two-tailed test) AP = Alkaline Phosphatase; CRP = C-reactive 
protein; IL-6 = Interleukin 6; TNFα = Tumor necrosis factor alpha; WBC =White blood 
cell count  
 
  Pyometra group 
Mean (±SD)   
N Control  Group 
Mean (±SD)   
N  
 
Ttest 
p-value 
Albumin  
(g/L) 
26.38 (±4.09)  45  33.9 (±3.0)  10  0.03 
AP  
(µkat/L) 
6.15 (±6.06)  53  1.37 (±0.58)  10  <0.0001 
Band 
neutrophils (%) 
12.04 (±9.5)  53  0.06 (±0.25)  16  <0.0001 
CRP   
(mg/L) 
207.66 (±92.46) 43 19.84  (±8.19)  10 <0.0001
Heart rate 
(beats/min) 
111.29 (±24.81) 48 102.00  (±52.66) 10 0.61
IL-6  
(pg/mL) 
172.62 (±249.25)  46  167.58 (±144.9)  19  0.98 
Platelet count  
(10
9/L) 
241.54(±121.4) 52 345.33(±111.5) 16 0.0395
Respiratory 
rate 
(Breaths/min) 
24.87 (± 9.68) 39 21.50  (±7.21)  10 0.23
Temperature   
(˚C)  
39.02  (±0.53) 52 38.97  (±0.27) 10 0.64
TNFα 
(pg/mL) 
0.13 (±0.073)  39  0.01(±0.012) 10 <0.0001
WBC    
(10
9/L) 
23.29 (±11.47)  53  9.03 (±2.7) 16 <0.0001
 
In both studies (II-III) an inflammatory leukogram was a common finding, 
reflected by a high average WBC and PBN. Of the 53 pyometra cases in study III, 
the WBC exceeded 16 000/µL in 36 cases (68%) and PBN exceeded 3 % in 44 
(83%) cases. The inflammatory leukogram is not a surprising finding in a disease 
characterized by chronic inflammation such as pyometra. Other common findings 
included increases in ALP (II and III), decreased platelet count, below 200 000/µL 
in 19 (37 %) of the dogs (III), decreased albumin (III), less than 25 g/L in 15 cases 
(33%), a non-regenerative anemia (III), and increases in the electrolytes sodium 
and chloride (III). Increased ALP was documented, in consistence with previous 
studies (Boerresen 1980, Boerresen & Skrede 1980). ALP exceeded the reference 
range (0-5 µkat/L) in 18 cases (34%) in study III. Intrahepatic cholestasis has been 
documented in bitches with pyometra (Boerresen & Skrede, 1980) and presents a 
reasonable explanation for the increases seen in ALP. Hypercholesterolemia, which 
was noted in 32/43 cases in study III (74%) (reference range 3.25-7.8 mmol/L), 
likely is another feature of intrahepatic cholestasis (Borresen & Skrede, 1980). A 
normocytic normochromic anemia, with PCV below 38%, was documented in   28
27/45 cases (60%) with an average mean corpuscular volume (MCV) of 67 fL 
(reference range 64-74) and average mean corpuscular hemoglobin content 
(MCHC) of 355g/L (reference range 335-363 g/L). This common finding is most 
likely representing anemia of chronic inflammation (Nelson & Couto, 1998). 
Hypernatremia was manifested in 13 of 45 cases (29%) (reference range 146-156 
mmol/L), and hyperchloremia in 15/45 cases (33%) (reference range 113-123 
mmol/L). Hypernatremia and hyperchloremia was thus seen in approximately 1/3 
of the pyometra cases (III) and was considered consistent with dehydration.  
 
  Azotemia was an unusual finding among dogs with pyometra. In study III, 
azotemia was noted in 3/50 cases (6 %) with serum creatinine exceeding the 
reference range (40-130µmol/L) but with only 2 of these cases (4%) showing 
increased BUN. In fact, in both studies (II-III) the pyometra dogs were more 
commonly showing a decrease in BUN (reference range 2.5-11.4 mmol/L), which 
was observed in 10 % (5/48 dogs). The decreased BUN is likely due to a 
combination of factors. Polyuria, seen in 71 % of the cases in study IV, leads to 
increased BUN excretion (Barsanti et al., 1999) and insufficient protein intake 
from inappetance may contribute to the decreased BUN (Barsanti et al. 1999). 
Hepatic insufficiency is another cause of decreased BUN, which theoretically 
could be associated with the noted ALP increases. However, study II showed that 
the bile acid test was in general normal which does not support decreased hepatic 
function. Also, increases of ALAT were rare. In study III only 4/54 cases (7%) 
showed increased ALAT (reference range <1.2 µkat/L). In study II, the ALAT 
among pyometra dogs were actually significantly lower than in the other groups. 
The decreases seen in the hepatocellular enzymes (ALAT and GLDH) in study II, 
are usually considered insignificant findings (Willard & Twedt, 1999). 
 
In study III, blood glucose abnormalities, and electrolyte abnormalities other 
than sodium and chloride, were rare findings. Hypoglycemia was affecting only 9% 
(4/47) of dogs and hyperglycemia was seen in 4 % (2/47) of pyometra dogs 
(reference range 3-6.5 mmol/L). Hypokalemia was seen in 2/45 cases (4%) 
(reference range 3.9-5.5 mmol/L), hyperkalemia in none, and hypochloremia in 
only 1 case (2%). Three of 47 cases (6 %) showed mild hypocalcemia, and none 
showed hypercalcemia. 
 
Of the 19 control dogs, 10 had previously been enrolled into the study and 
treated for pyometra. In these dogs, all hematology parameters had returned to 
normal after a median of 64 days (range 57-111 days). The blood biochemical 
panel in one of the dogs showed mild increases in serum creatinine and ALAT and 
moderate hypernatremia and hyperchloremia. Hemoconcentration from 
dehydration was assumed, which showed no other abnormalities in blood work, 
history or physical examination. In addition to this dog, 3 dogs showed mild 
hyperchloremia and two of them also showed hypernatremia. Mild dehydration was 
assumed in these dogs. Three dogs showed mild hypercholesterolemia and a 
postprandial response could not be ruled out. Thus, with none of these dogs 
showing significant abnormalities in the blood work, paired with a normal clinical 
status, the organ dysfunction in pyometra appears to be of a reversible nature after 
ovariohysterectomy.  
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Endotoxin (II) 
Studies II and III primarily dealt with the systemic effects of the uterine infection. 
In study II the hypothes was that endotoxemia would be associated with more 
severely affected clinical status. Endotoxin determinations were performed on 92 
plasma samples. However, endotoxinemia was detected in only four bitches with 
pyometra (in three of them before surgery and in one after surgery). Endotoxin was 
also detected in one bitch with non-inflammatory uterine disease and in 2 healthy 
control dogs. The ET levels in these 7 cases ranged from 14.2 pg/L to 14.5 ng/L. 
Of the 4 bitches with pyometra and detectable plasma ET, 2 had uterine growth of 
E. coli, 1 showed no growth and 1 showed growth of Streptococcus canis. The fact 
that endotoxin was detected in healthy control dogs indicated that contamination of 
the samples, alternatively assay errors, might have led to the inconsistent findings. 
These results are in sharp contrast to other studies (Wessels & Wells, 1989 and 
Okano et al 1998). One explanation for the absence of endotoxinemia might have 
been that the clinical status of the dogs was not severe enough to be consistent with 
“spill-over” effects of ET. In general, the clinical status of the population of dogs 
in study II was normal or only mildly impaired, and none showed the expected 
severely affected general attitude associated with a massive release of ET 
(Rietschel & Brade, 1992). The majority of the dogs in study II did however show 
a severe inflammatory leukogram that could represent a response to low 
concentrations of circulating ET (Van Miert & Frens, 1968). Certainly, the study 
population in study III-IV, which likely is very similar to the population in study II, 
showed many of the clinical signs associated with experimentally induced low dose 
endotoxemia, i.e. fever (33%), lethargy (71%), tachycardia (23%) and tachypnea 
(32%) (Van Miert & Frens, 1968). It is possible that ET indeed is responsible for 
the systemic effects of pyometra, but that the release of ET from the uterus is 
intermittent and difficult to demonstrate with a one-point-in-time test such as in 
study II.  
 
Systemic inflammatory response syndrome (III) 
Study III included a total of 53 pyometra dogs, of which 30 (57%) were positive 
for SIRS according to criteria levels defined by Hauptman, Walshaw & Olivier 
(1997) and 23 (43%) were SIRS negative. Dogs positive for SIRS showed an 
average onset of 8 (±6.39) days, whereas SIRS negative dogs showed a slightly 
shorter duration of clinical signs (4.5±4.32 days). The difference in duration was 
notable, but did not quite reach statistical significance (p-value 0.055). 
 
Any clinical scoring system appears relatively non-specific, including the SIRS 
criteria in dogs (specificity 64%; Hauptman et al., 1997). This is logical, 
considering that there are many reasons for hyperthermia, tachycardia and 
tachypnea, other than systemic inflammation, such as anxiety and pain (Lucas et 
al., 2001). Multiple human studies have evaluated different inflammatory 
mediator’s ability to more specifically act as markers for sepsis/SIRS and 
predictors of outcome (Reny et al., 2002; Marik, 2002; Harbarth et al., 2001; 
Whicher et al 2001; Bossink et al., 1998). The consensus seems to be that out of 
many studied markers (i.e. TNFα, IL-1, IL-6, IL-8, IL-1 receptor antagonist, CRP, 
procalcitonin, E-selectin, soluble intercellular adhesion molecule-1, protein C,   30
leukocyte elastase, granulocyte colony-stimulating factor, complement 3a, 
erythropoietin, serum amyloid protein, neopterina and plasma nitrite/nitrate 
concentrations) procalcitonin and CRP appears to have the most utility (Reny et 
al., 2002; Marik, 2002). Procalcitonin determinations are at present available 
through one manufactured assay, for humans only as this protein shows structural 
species differences, making cross-reactivity unlikely (pers. comm. Christiane 
Dinter, Brahms Aktiengesellschaft, Hennigsdorf, Germany, 2003). Therefore, 
procalcitonin determinations were not part of our study. 
 
When we searched for parameters associated with positive or negative SIRS 
status in pyometra dogs we chose to investigate not only the classical SIRS 
parameters (body temperature, heart rate, respiratory rate, WBC and PBN) but in 
addition platelet count, ALP, albumin, IL-6, TNFα and CRP. The additional 
parameters were selected based on that the platelet count has previously been 
shown to significantly differ between dogs with and without sepsis (Hauptman, 
Walshaw & Olivier, 1997). Albumin was included due to its propensity to act as a 
negative acute phase protein (Werner & Turnwald, 1999).  Alkaline phosphatase 
was studied based on previous finding of this enzyme being significantly increased 
in pyometra cases as compared to normal (study II) and this enzyme appears to 
reflect the level of hepatic impairment with respect to cholestasis (Borreson & 
Skrede, 1980). The inflammatory mediators IL-6 and TNFα, and the acute phase 
protein CRP, have been shown to be increased in human patients with SIRS 
(Spielmann et al., 2001; Gogos et al., 2001). Serum glucose was not included as a 
SIRS criteria based on a previous study indicating no significant differences in 
glucose concentration in dogs with and without sepsis (Hauptman, Walshaw & 
Olivier, 1997) which is in agreement with the results in study III. The mean values 
for the selected clinical criteria, haematology and blood biochemical parameters, 
IL-6, TNFα and CRP, in the SIRS positive group and the SIRS negative group are 
presented in Table 8. 
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Table 8. Mean and standard deviations for clinical parameters (body temperature, heart 
rate, respiratory rate), hematology (WBC, percent band neutrophils, platelet count), blood 
biochemistry (AP, Albumin), and inflammatory markers (CRP, TNFα and IL-6) in dogs 
with pyometra. The SIRS group consists of dogs with 2 or more positive SIRS criteria17 
and the No SIRS group of dogs with less than 2 positive SIRS criteria. P-values were 
calculated using Two-sample unequal variance Student’s T-test (two-tailed test). 
AP=Alkaline Phosphatase; CRP=C-reactive protein; IL-6=Interleukin 6; PBN= Percent 
band neutrophils; TNFα=Tumor necrosis factor alpha; WBC =White blood cell count    
   
  SIRS Group 
Mean (±SD)  
 
N  
No SIRS  
Mean (±SD) 
 
N 
Ttest 
p-value 
Albumin  
(g/L) 
26.21 (±4.19)  24  26.57 (±4.07)  21  0.77 
AP  
(µkat/L)
6.67 (±7.3) 30 5.65  (±4.14)  21 0.53 
PBN  
(%) 
11.90 (±9.59) 30 11.88  (±9.62) 23 0.99
CRP   
(mg/L) 
235.49(±79.8)  22 178.51  (±97.55)  21 0.0398 
Heart rate 
(beats/min) 
121.00(±26.9)  27 98.10  (±13.32)  21 0.0004 
IL-6  
(pg/mL) 
180.90(±265.5) 24 156.05  (±232.13)  22 0.74
Platelets 
 (10
9/L) 
239.76(±124.4) 29 236.22  (±123.28)  23 0.91
Respiratory rate 
(breaths/min) 
23.48 (±6.94)  25  27.36 (±13.21)  14  0.32 
Temperature 
(˚C)
39.23 (±0.56) 30 38.74  (±0.33) 22 0.0002
TNFα  
(pg/mL) 
0.12 (±0.06) 20 0.14  (±0.09) 19 0.61
WBC  
(10
9/L) 
23.98 (±11.55) 30 22.47  (±11.33)  23 0.63
 
To the author’s knowledge, study III was the first to evaluate the use of the 
inflammatory mediators TNFα and IL-6 or the acute phase protein CRP as markers 
for SIRS in dogs. None of the hematology and blood biochemical parameters or 
the inflammatory mediators TNFα and IL-6, chosen for their possible ability to 
predict SIRS, was confirmed to have such abilities.  In our population CRP was the 
only biochemical marker that was significantly (p-value 0.0372) associated with 
SIRS. Of the classical criteria for SIRS (heart rate, respiratory rate, body 
temperature, WBC and PBN) the heart rate (p-value 0.0003) and the body 
temperature (p-value=0.0005) were significantly different in SIRS positive versus 
negative dogs. In fact, multiple logistic regression showed that in the study 
population (III) a combination of CRP, heart rate and body temperature, was the 
most effective way (p-value <0.0001) to discriminate between SIRS positive and 
SIRS negative dogs. Figure 1 presents a contour plot of the 95% estimated 
probability of a dog to be SIRS positive given the values for CRP, heart rate and 
body temperature.  If the levels for CRP and heart rate bisect each other to the right   32
of the curve representing the body temperature, the probability is at least 95% for 
that dog to be SIRS positive. If the bisecting values are located to the left of the 
curve the probability is less than 95% for the case to represent a SIRS positive dog.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Estimated 0.95 probability of an animal being affected with systemic 
inflammatory response syndrome (SIRS) using values for body temperature, heart rate (HR) 
and plasma C-reactive protein (CRP). Bisection of the values for CRP and HR to the right 
of the curve corresponding with body temperature in an animal indicates a 95% probability 
of SIRS. 
 
This graph (Figure 1) was generated through multiple logistic regression as a 
function of the formula:  Estimated Probability of SIRS  = 
exp(-198.5 + 4.6971*temperature + 0.0169*CRP + 0.1077*heart rate) 
1 + exp(-198.5 + 4.6971*temperature + 0.0169*CRP + 0.1077*heart rate) 
 
Studies of human patients with positive SIRS criteria have clearly shown the 
association of SIRS with increased morbidity and/or inferior outcome (Bochicchio 
et al., 2002; Buter et al., 2002; Afessa et al., 2001; Sun & Aikawa, 1999; Bossink, 
1998 & Shoenberg et al., 1998). Only two studies regarding outcome related to 
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SIRS in dogs have been presented prior to our study (Welzl et al., 2001; Okano et 
al., 2002). The former study did not find SIRS, nor the precense of MODS, able to 
predict outcome, manifested as death or euthanasia, in dogs with babesiosis and the 
authors requested more sensitive and specific definitions of SIRS in dogs. 
However, one may speculate if the systemic effects of babesiosis might reflect the 
effect of hemolysis and disseminated intravascular coagulation, as well as the 
systemic inflammatory response. In addition, the study appeared to define MODS 
with less stringent criteria compared to other studies. In contrast, Okano and co-
workers (2002) showed a significant correlation between SIRS and increased 
mortality. Our study (III) did show a significant association between a positive 
SIRS status and outcome, estimated as number of hospitalization days.  One can 
argue that the hospitalization length offers an extremely crude estimation of 
morbidity. None the less, this is a factor also used in human studies of SIRS 
(Afessa et al., 2001).   
 
Study III appears to be the first to evaluate the use of haematology and 
biochemical parameters and the inflammatory mediators TNFα and IL-6, or the 
acute phase protein CRP as predictors of outcome in dogs. In the population CRP 
was the only biochemical marker related to SIRS, and in addition, CRP was in 
itself a significant predictor of outcome. The regression analysis of plasma CRP 
versus length of hospitalization is illustrated in figure 2. The graph is based on the 
regression function: Days hospitalization =1.04553+0.0034538 CRP  
This function reveals that a plasma CRP greater than 276.35 mg/L is associated 
with hospitalization exceeding 2 days. The results provide encouragement for 
further studies of CRP as a predictor of morbidity/mortality in dogs.  
 
Cystic endometrial hyperplasia versus pyometra (II, IV) 
The concept of CEH-pyometra introduced by Dow (1957) has lately been 
questioned (De Bosshere et al., 2001). Regardless of the discussion of similarities 
or discrepancies in the underlying etiopathogenesis, the lack of bacterial infection 
in CEH, as reflected in study II, leads to many differences in the clinical 
presentation between this disorder and pyometra. Thus, the signalment, history and 
physical examination as well as haematology and blood biochemical findings have 
classically been considered of great importance when trying to predict a final 
diagnosis of pyometra vs. CEH/mucometra. Severe systemic affection as reflected 
by inflammatory leukogram or decreased general attitude has not been 
demonstrated in CEH. However, despite the differences in presentation and blood 
work, CEH and pyometra can be difficult to separate clinically. The diagnostic 
image of uteri with these disorders can be deceiving, since fluid can accumulate in 
the uterus in both diseases, in CEH mucus and in pyometra pus (Study II and IV, 
De Bosschere et al. 2002). For the clinician trying to decide whether to perform 
emergency surgery or to wait until more ideal circumstances are available, 
differentiation between the two diagnosis can be crucial in order to avoid the 
critical situation where delayed surgery of a pyometra dog leads to a ruptured 
uterus.  
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Figure 2. Length of hospitalisation versus plasma C-reactive protein (CRP) in 53 bitches 
with pyometra. A plasma CRP exceeding 276.35 mg/L predicts a hospitalisation length 
exceeding what is considered normal, i.e. 1-2 days. 
 
Study IV investigated the benefit of signalment, history and physical exam 
findings, hematology parameters and biochemical parameters, including TNFα and 
CRP, in the differentiation between pyometra and CEH. The signalment (age and 
breed) did not show significant differences between pyometra dogs as compared to 
dogs with CEH. The average age of the CEH dogs was slightly lower (6.6 years) as 
compared to pyometra cases (8.4 years) but the respective ranges were wide and 
the difference in average age did not reach statistical significance. The frequency 
of clinical signs and the significance of the differences in clinical signs between 
bitches with pyometra and bitches with CEH/mucometra are presented in Table 9. 
The number of days of clinical signs prior to admission ranged from 1 to 28 days 
with a mean of 6.5 (±5.8) days. Of these four most commonly reported clinical 
signs,  i.e. vaginal discharge, polyuria/polydipsia, lethargy and 
vomiting/inappetance, the latter three were significantly different between the two 
groups of dogs. In addition, a dog with only one of these clinical signs observed by 
the owner is significantly more likely to represent a dog with CEH, whereas a dog 
showing 3 or more of these signs is more likely to represent a pyometra case. In 
contrast to the multiple differences in clinical signs the general physical 
examination showed limited ability to differentiate between a dog with pyometra 
from a dog with CEH. The general attitude was the only discriminative finding, 
with a dog presenting bright and alert being significantly more likely to be 
diagnosed with CEH than pyometra. The frequencies of physical examination 
findings are presented in Table 10. 
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Table 9. Differences in the presence of vaginal discharge, polyuria/polydipsia, lethargy and 
gastrointestinal signs, i.e. vomiting and/or inappetance, between dogs with pyometra and 
dogs with cystic endometrial hyperplasia (CEH)/Mucometra. P-values calculated with 
Fisher’s exact test (two-tailed test) 
  
 
Pyometra 
N=48 
 
CEH 
N=9 
 
P-value 
Vaginal discharge 
25 (52%)  6 (67%)  0.49 
Polyuria/polydipsia  34 (71%)  2 (22%)  0.0090 
Lethargy  34 (71%)  2 (22%)  0.0090 
Vomiting/ 
inappetance 
36 (75%)  1 (11%)  0.0005 
Only 1 clinical sign  6 (12%)  6 (67%)  0.0015 
≥ ≥ ≥ ≥3 clinical signs  29 (60%)  1 (11%)  0.0095 
 
The results (IV) from hematology, blood biochemistry, plasma TNFα and plasma 
CRP determinations are presented in Table 11 and the significance of differences 
in these parameters are presented in Table 12. Multiple logistic regression showed 
that an elevated PBN in combination with high plasma CRP identified pyometra 
with few false negative results (sensitivity 97.7 %) as confirmed by 
histopathological examination. The specificity was fairly low (75 %) in this 
combination. The combination of elevated PBN and ALP showed a slightly higher 
specificity (77.8%) but with a lower sensitivity (96.1%). Any other combinations 
of two or more parameters did not increase the sensitivity or specificity in the 
prediction of pyometra as the diagnosis. Figure 3 presents a contour plot of the 95 
% and 80 % estimated probability of a dog having pyometra, in contrast to CEH, 
given the values of PBN and CRP. This contour plot was generated from the 
regression analysis and illustrates the formula: Estimated Probability of Pyometra 
=  
exp(-2.3110 + 0.2643*band percent + 0.0202*CRP) 
1 + exp(-2.3110 + 0.2643*band percent + 0.0202*CRP) 
 
For clinicians, a test with high sensitivity in the prediction of pyometra vs. 
CEH/mucometra is desirable. The sensitivity of the test is probably of higher 
importance than the specificity since it is reasonable to assume that emergency 
surgery on a dog that is not critically ill, i.e. CEH/ mucometra, would be less 
hazardous than the risk associated with a delay in surgery for a pyometra dog, 
which potentially could rupture an infected uterus. Thus, using the 80% probability 
plot in figure 3, associated with a high sensitivity but less specificity would be   36
safer. In contrast, the 95% probability plot provides a higher specificity in the 
diagnosis of pyometra versus CEH/mucometra.  
 
 
Table 10. Differences in the percentage of physical examination abnormalities between 
dogs with pyometra and dogs with cystic endometrial hyperplasia (CEH)/mucometra. P-
values calculated with Fisher’s exact test (two-tailed test) 
 
  Pyometra       n=51  CEH               n=9 
 
P-value 
Temperature  
> 39.2° ° ° °C 
17 (33%)             51  1 (11%)                9  0.26 
Heart rate  
> 120 beats/minute 
11 (23%)             47  0 (0%)                  9  0.18 
Respiratory Rate 
> 20 breaths/minute 
13 (32%)             40  4 (50%)                8  0.43 
Abdominal pain on 
palpation 
37 (76%)             49  5 (56%)                9  0.24 
Attitude 
Bright and Alert 
7 (14%)               49  6 (67%)                9  0.0025 
Attitude ≥ ≥ ≥ ≥ moderately 
depressed 
15 (31%)             49  2 (22%)                9  1.00 
 
Mucus membranes 
Pale or Hyperemic 
12 (24%)             50  0 (0%)                  9  0.18 
 
 
C-reactive protein in canine uterine disorders (Study III and IV) 
In study III the laboratory parameters that differed between diseased and healthy 
animals were albumin, AP, PBN, platelet count, TNFα, WBC and CRP. Of these, 
only the latter was able to distinguish between SIRS positive and SIRS negative 
dogs. Also, when evaluating possible correlation between all clinical and 
laboratory parameters previously found associated with SIRS (temperature, WBC, 
PBN, heart rate [HR], respiratory rate, platelet count, CRP, TNFα and IL-6), only 
the temperature, the HR and the CRP was statistically related to SIRS. CRP 
showed a less significant correlation with SIRS than temperature and HR (p-
value=0.0003), but one must bear in mind that the latter two criteria are part of the 
definition of SIRS.  
 
To the author’s knowledge, CRP has not previously been used for prediction of 
severity in diseased animals or to predict outcome. A possible limitation of CRP as 
a predictor of outcome and severity of disease is the fact that CRP can show a high 
individual variability (Reny et al. 2002), which was also reflected by study III. 
This makes certain conclusions based on an individual value more difficult, and in 
human intensive care procalcitonin is emerging as a more novel and possibly more 
accurate tool in diagnosis of sepsis (Marik, 2002). Regardless, CRP and 
procalcitonin appears to be the most valuable predictors of sepsis available in 
human intensive care today and of these two, only CRP is available for use in dogs 
(Marik, 2002). 
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Table 11. Mean and standard deviation for selected hematology parameters (hemoglobin, 
WBC, % band neutrophils, platelet count), blood biochemical parameters (AP, Albumin), 
CRP and TNFα in dogs with Pyometra or Cystic endometrial hyperplasia (CEH) or healthy 
dogs (Controls AP=Alkaline phosphatase; CRP=C-reactive protein; TNFα=Tumor 
necrosis factor alpha; WBC= White blood cell count 
 
 
 Pyometra 
Mean (± ± ± ±S.D.) 
N=54 
CEH 
Mean (± ± ± ±S.D.) 
N=10 
Controls 
Mean (± ± ± ±S.D.) 
N=10 
Hemoglobin 
(g/L) 
139.23 (±24.52) 
53 
136.90 (±19.85) 
10 
168.80 (±16.83) 
10 
WBC    
(10
9/L) 
23.31 (±11.45) 
53 
10.19 (±5.44) 
10 
8.22 (±1.67) 
10 
Band neutrophils  
(%) 
12.58 (±9.77) 
53 
1.69 (±3.78) 
10 
0.00 (±0.00) 
10 
Platelet count  
(10
9/L) 
233.27 (±125.28) 
52 
251.67 (±110.50) 
9 
307.20 (±128.65) 
10 
AP 
(µkat/L) 
6.15 (±6.06) 
54 
2.26 (±2.30) 
9 
1.37 (±0.58) 
10 
Albumin 
(g/L) 
26.83 (±4.39) 
48 
30.57 (±3.64) 
7 
33.90 (±2.96) 
10 
CRP   
(mg/L) 
200.28 (±93.51) 
47 
53.51 (±66.24) 
8 
19.84 (±8.19) 
10 
TNFα α α α 
(pg/mL) 
0.13 (±0.07) 
43 
0.12 (±0.05) 
7 
0.01 (±0.01) 
10 
 
The results from study IV showed that an elevated PBN in combination with 
high plasma CRP showed the highest sensitivity (97.7 %) of all possible 
combinations of the investigated parameters in the prediction of whether a dog with 
a fluid filled uterus will have the diagnosis pyometra confirmed by 
histopathological examination. For the clinician trying to decide whether to 
perform emergency surgery or to wait until more ideal circumstances are available, 
the sensitivity of the test is probably of higher importance than the specificity. It is 
reasonable to assume that emergency surgery on a dog that is not critically ill, i.e. 
CEH, would be less hazardous than the risk associated with a delay in surgery for a 
pyometra dog, that potentially could rupture an infected uterus. Therefore it seems 
logical to use the parameters with the highest sensitivity in the prediction of the 
diagnosis. However, clinically this requires that a reliable, rapid, and preferably 
cheap CRP assay is available at all times, as well as a differential WBC. In contrast 
to WBC, which is part of routine blood work at most small animal hospitals, this is 
not presently the case for CRP. The most popular commercially available canine 
assay today is a relatively expensive and time-consuming ELISA. This contrasts 
the automated CRP assays (nephelometric or turbidometric) available for humans. 
Structural differences in canine CRP as compared to human CRP have previously 
been considered to preclude the use of human diagnostics for dogs (Yamamoto et   38
al., 1993). However, a commercially available human turbidometric CRP assay 
was recently showed to reliably measure canine serum CRP levels as well 
(Kjelgard-Hansen, Jensen & Kristensen, 2003). The benefits of CRP determination 
in human medicine are extensive in several different fields, reflected by the 
development of this assay into a relatively inexpensive routine 24-hour blood work 
(Reny et al. 2002). Our studies are likely only the first in a multitude of future 
reports on benefits of CRP as a diagnostic aid in veterinary medicine.  
 
Table 12. Significance of differences in selected hematology parameters (hemoglobin, 
WBC, % band neutrophils, platelet count), blood biochemical parameters (AP, Albumin), 
CRP and TNFα  in dogs with Pyometra or Cystic Endometrial Hyperplasia (CEH) or 
healthy dogs (Controls). Two-sample unequal variance Student’s T-test (two-tailed test) 
was used to calculate p-values. A p-value of <0.05 is considered significant and these p-
values are indicated with bold figures. AP=Alkaline phosphatase; CRP=C-reactive 
protein; TNFα=Tumor necrosis factor alpha; WBC=White blood cell count 
 
 
Pyometra 
vs. Control 
p-value 
 
CEH vs. 
Control 
p-value 
 
Pyometra vs. 
CEH 
p-value 
Albumin 
(g/L) 
<0.0001  0.12  0.0365 
AP 
(µkat/L) 
<0.0001 0.0437  0.0016 
Band neutrophils 
(%) 
<0.0001 0.004  <0.0001 
CRP   
(mg/L) 
<0.0001  0.28  0.0001 
Hemoglobin 
(g/L) 
<0.0001 0.0012  0.93 
Platelet count  
(10
9/L) 
0.12  0.0092  0.66 
TNFα α α α 
(pg/mL) 
<0.0001 0.0012  0.58 
WBC    
(10
9/L) 
<0.0001 0.0023  <0.0001 
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Figure 3. Contour plot of estimated 95% (solid graph) and 80 % (dotted graph) probability 
of the diagnose pyometra, based on plasma C-reactive (CRP) concentration and the percent 
band neutrophils (PBN) from the differential white blood cell count. If values for CRP and 
PBN are bisecting to the right of the graph there is a 95% or 80% , respectively, probability 
that the diagnosis is pyometra in contrast to Cystic Endometrial Hyperplasia (CEH).  
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General conclusions 
 
The following conclusions can be drawn from this series of investigations: 
 
•  Escherichia coli isolated from the uterus of bitches with pyometra showed a 
higher degree of clone similarity than would have been expected from a random 
population. This indicates that E. coli causing pyometra are descendants of certain 
clones. 
 
• Identical E. coli clones were found in the rectum and the uterus of bitches with 
pyometra, indicating that the infection ascends into the uterus from the intestinal 
bacterial flora. 
 
• Identical E. coli clones were isolated from the uterus and the urinary tract in 
bitches with pyometra and concomitant urinary tract infection. The primary 
infection site is however not determined. 
 
• Commmon hematology and blood biochemical abnormalities in bitches with 
pyometra versus non-inflammatory uterine disease or versus healthy controls 
include an inflammatory leukogram with a left shift, non-regenerative anemia of 
chronic inflammation, mildly elevated ALP, hypercholesterolemia, hypernatremia 
and hyperchloremia from hemoconcentration and decreased serum urea nitrogen. 
Uncommon abnormalities (<10 % of dogs) include azotemia, hypo- or 
hyperglycemia, hypocalcemia, hypokalemia, and elevations of ALAT. Results of 
preprandial bile acids, bilirubin or GLDH are in general within normal limits. 
 
•  Endotoxemia was not consistently demonstrated in bitches with pyometra. 
 
• Two out of four criteria for systemic inflammatory response syndrome (SIRS) 
were fulfilled in 57 % of bitches with pyometra.  
 
•Of hematology parameters, blood biochemical parameters, tumor necrosis factor 
α, interleukin 6 or C-reactive protein (CRP), CRP, despite notable individual 
variation, was the only parameter that was significantly related to SIRS, with the 
exception of the clinical criteria that defines this syndrome. A combination of body 
temperature, heart rate and CRP was most strongly related to SIRS as compared to 
all other parameters alone or grouped. 
 
•  In bitches with pyometra, a positive SIRS status, high plasma CRP concentration 
and high body temperature are significant predictors of increased morbidity as 
reflected by length of hospitalization.  
 
•  Of diagnostic laboratory work, the percent band neutrophils (PBN) in 
combination with CRP are highly sensitive in the prediction of the diagnosis 
pyometra versus cystic endometrial hyperplasia/mucometra (CEH). Alkaline 
phosphatase in combination with PBN showed a slightly increased specificity 
(77.8%) at the cost of decreased sensitivity in the prediction of pyometra. In  41 
addition, the presenting clinical signs as well as the general attitude of the dog were 
shown to be helpful in the differentiation between pyometra and CEH.  
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